We found 7 drugmaker programs for Cholangiocarcinoma medicines and 3 charity funds (0 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Cholangiocarcinoma depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Copays, coinsurance, deductibles and other health-related expenses.
Covers: Copays, coinsurance and deductibles for treatment.
Covers: Out-of-pocket costs for approved medications. Up to $6,200 a year.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
IMFINZI Patient Savings Program: eligible commercially insured patients may pay as little as $0 per infusion, no income requirement. Not for government insurance.
Up to $100 per infusion toward administration costs. Not available to Massachusetts or Rhode Island residents.
IMFINZI is on the AZ&Me list. AZ&Me gives AstraZeneca medicines at no cost to eligible uninsured people or Medicare patients who cannot afford them.
Access 360 answers questions about insurance coverage, out-of-pocket costs and patient assistance programs.
Free drug is through AZ&Me (1-800-292-6363); income limits apply. AZ&Me eligibility is described at azandmeapp.com.
The Merck Access Program helps with insurance coverage questions, co-pay assistance options for eligible patients, and eligibility for free medicine.
Merck Patient Assistance Program gives Keytruda free for up to 1 year to eligible US residents without coverage who meet income limits; hardship exceptions possible.
Keytruda.com mentions co-pay assistance options for eligible patients but gives no specific co-pay offer terms, so none is listed. Free drug is through the separate Merck Patient Assistance Program, Inc.; income limits apply.
Brand site says Care Connect offers co-pay assistance. Eligibility and amounts are not published yet.
Brand site says Care Connect offers prescription assistance. Eligibility is not published yet.
LYRFIGTU was FDA approved Sept 23, 2026 and Elevar says it expects US availability by Q4 2026; the Care Connect page says 'Available Soon'. Program terms, eligibility and dollar limits are not yet posted. Call Care Connect (1-833-T0GETHR, Mon-Fri 8AM-8PM ET). Recheck after launch.
$0 co-pay program for eligible commercially insured patients.
Patient assistance program provides free medication to eligible uninsured or underinsured patients.
Benefits review, specialty pharmacy coordination, optional nurse support, and referrals to foundations and Medicare Extra Help.
Full eligibility criteria at taihopatientsupport.com. Phone is 1-844-TAIHO-4U.
Eligible patients with commercial prescription coverage may pay as little as $0; annual benefit maximum applies. Medicare, Medicaid, TRICARE and uninsured patients are not eligible.
Free PEMAZYRE for uninsured patients, Medicare Part D patients, or patients whose coverage was exhausted or denied, if they meet household income criteria.
Free 30-day supply if coverage for an FDA-approved use is delayed; proof of the submitted insurance claim and delay is required.
Help understanding insurance coverage, pharmacy outreach call at start, financial assistance options, and referrals to advocacy organizations.
PEMAZYRE is filled through Biologics by McKesson specialty pharmacy. Patients in Alternate Funding Programs are not eligible for free drug. Phone line Mon-Fri 8 AM-8 PM ET.
Commercial co-pay program lowers out-of-pocket costs for commercially insured patients; no income restrictions. Government insurance not eligible.
Patient Assistance Program may provide Tibsovo to uninsured or underinsured patients; income requirements apply.
Patients waiting for insurance coverage may be eligible for a free product program; contact ServierONE.
ServierONE works with patients, caregivers and doctors on getting treatment started and can refer government-insured patients to independent foundations.
Copay enrollment is at servierone-copay.com. Servier customer service is 1-800-807-6124. servierone.com did not load in this check; program details confirmed on tibsovo.com.
Eligible commercially insured patients may pay as little as $0 per prescription, subject to an annual maximum.
Uninsured or underinsured patients who meet financial criteria may get ZIIHERA at no cost.
Help with benefits investigations, prior authorizations and appeals, and referrals to other financial assistance.
The patient page says copay may be as little as $0; the HCP page (BTC) says as little as $10. Confirm the current amount with JazzCares. Phone 1-833-533-JAZZ, Mon-Fri 8 AM-8 PM ET.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 7 drugmaker programs for Cholangiocarcinoma medicines and 3 charity funds, 0 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Cholangiocarcinoma, 0 charity funds on this page accept Medicare, and 2 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
None of the 3 funds listed for Cholangiocarcinoma was open to new applicants at our last check. Funds reopen when new donations arrive, and each foundation lets you sign up to hear when one opens.
Of the drugmaker programs for Cholangiocarcinoma medicines, 6 offer free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (The Assistance Fund, CancerCare Co-Payment Assistance Foundation, TotalAssist) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
